Literature DB >> 12549534

An outbreak of Barmah Forest virus disease in Victoria.

Jonathon Passmore1, Kerry Ann O'Grady, Rodney Moran, Elwyn Wishart.   

Abstract

This report describes the epidemiological and clinical features of an outbreak of 47 cases of laboratory-confirmed Barmah Forest virus disease (BF disease) that occurred in Victoria between January and May 2002. Laboratory-confirmed cases were investigated, and information on travel history and clinical details was collected. Surveillance data from adult mosquito trappings and climatic conditions in the Wellington Shire were also reviewed. The response rate for interviews was 85 per cent (40/47). The most common symptoms reported by cases included arthralgia (95%), lethargy (90%) and maculopapular rash (72.5%). Transmission of BF disease in the Gippsland region was associated with unusually high numbers of Ochlerotatus camptorhynchus mosquitoes. This outbreak was of interest due to the fact that cases of BF disease outnumbered cases of Ross River virus disease (RR disease) in Victoria for the first time since data were available. Similar outbreaks of BF disease, in the absence of RR disease, occurred in Western Australia in 1993 and New South Wales in 1994/1995. Although the majority of BF disease cases reported regular outdoor activity during which they could be exposed to mosquito populations, they infrequently take precautions to limit exposure. Further efforts need to be made to educate people of the importance of using repellents and other personal preventative measures.

Entities:  

Mesh:

Year:  2002        PMID: 12549534

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  8 in total

1.  Surveillance should be strengthened to improve epidemiological understandings of mosquito-borne Barmah Forest virus infection.

Authors:  Lutz Ehlkes; Keith Eastwood; Cameron Webb; David Durrheim
Journal:  Western Pac Surveill Response J       Date:  2012-08-02

Review 2.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

3.  Phylogenetic and Timescale Analysis of Barmah Forest Virus as Inferred from Genome Sequence Analysis.

Authors:  Alice Michie; Timo Ernst; I-Ly Joanna Chua; Michael D A Lindsay; Peter J Neville; Jay Nicholson; Andrew Jardine; John S Mackenzie; David W Smith; Allison Imrie
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.048

4.  Quantitative PCR assay for the detection of Aedes vigilax in mosquito trap collections containing large numbers of morphologically similar species and phylogenetic analysis of specimens collected in Victoria, Australia.

Authors:  Peter T Mee; Shani Wong; Karen Brown; Stacey E Lynch
Journal:  Parasit Vectors       Date:  2021-08-28       Impact factor: 3.876

5.  Correlation between Buruli Ulcer Incidence and Vectorborne Diseases, Southeastern Australia, 2000-2020.

Authors:  Jake Andrew Linke; Eugene Athan; N Deborah Friedman
Journal:  Emerg Infect Dis       Date:  2021-12       Impact factor: 6.883

Review 6.  The Putative Roles and Functions of Indel, Repetition and Duplication Events in Alphavirus Non-Structural Protein 3 Hypervariable Domain (nsP3 HVD) in Evolution, Viability and Re-Emergence.

Authors:  Nurshariza Abdullah; Nafees Ahemad; Konstantinos Aliazis; Jasmine Elanie Khairat; Thong Chuan Lee; Siti Aisyah Abdul Ahmad; Nur Amelia Azreen Adnan; Nur Omar Macha; Sharifah Syed Hassan
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

7.  Correlation between Buruli ulcer and vector-borne notifiable diseases, Victoria, Australia.

Authors:  Paul D R Johnson; Caroline J Lavender
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

Review 8.  Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis.

Authors:  Iranaia Assunção-Miranda; Christine Cruz-Oliveira; Andrea T Da Poian
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.